Determination of the Effective Individual Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis
Phase of Trial: Phase IV
Latest Information Update: 07 Jul 2017
Price : $35 *
At a glance
- Drugs Etanercept (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Pharmacogenomic; Pharmacokinetics
- Acronyms Etaplus
- 03 Jul 2017 Status changed from active, no longer recruiting to completed.
- 30 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 08 Oct 2015 Planned number of patients changed from 120 to 140 as per ClinicalTrials.gov record.